[go: up one dir, main page]

NO972623D0 - Framasöytisk blanding omfattende lamotrigin - Google Patents

Framasöytisk blanding omfattende lamotrigin

Info

Publication number
NO972623D0
NO972623D0 NO972623A NO972623A NO972623D0 NO 972623 D0 NO972623 D0 NO 972623D0 NO 972623 A NO972623 A NO 972623A NO 972623 A NO972623 A NO 972623A NO 972623 D0 NO972623 D0 NO 972623D0
Authority
NO
Norway
Prior art keywords
pct
lamotrigine
formula mixture
date jun
sec
Prior art date
Application number
NO972623A
Other languages
English (en)
Other versions
NO972623L (no
Inventor
Simon Philip Hiskett
Susan Ann Taylor
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO972623D0 publication Critical patent/NO972623D0/no
Publication of NO972623L publication Critical patent/NO972623L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO972623A 1994-12-07 1997-06-06 Farmasöytisk blanding omfattende lamotrigin NO972623L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424766.5A GB9424766D0 (en) 1994-12-07 1994-12-07 Pharmaceutical composition
PCT/GB1995/002865 WO1996017611A1 (en) 1994-12-07 1995-12-07 Pharmaceutical composition comprising lamotrigine

Publications (2)

Publication Number Publication Date
NO972623D0 true NO972623D0 (no) 1997-06-06
NO972623L NO972623L (no) 1997-08-06

Family

ID=10765604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972623A NO972623L (no) 1994-12-07 1997-06-06 Farmasöytisk blanding omfattende lamotrigin

Country Status (19)

Country Link
US (1) US5861179A (no)
EP (1) EP0797441B1 (no)
JP (1) JP2977284B2 (no)
CN (1) CN1174505A (no)
AT (1) ATE213633T1 (no)
AU (1) AU696406B2 (no)
BR (1) BR9509975A (no)
CA (1) CA2207284A1 (no)
CZ (1) CZ171797A3 (no)
DE (1) DE69525649T2 (no)
ES (1) ES2172600T3 (no)
FI (1) FI972434A (no)
GB (1) GB9424766D0 (no)
HU (1) HUT77367A (no)
NO (1) NO972623L (no)
NZ (1) NZ296573A (no)
PL (1) PL320560A1 (no)
RU (1) RU2160106C2 (no)
WO (1) WO1996017611A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
WO1998036737A1 (en) * 1997-02-25 1998-08-27 The Procter & Gamble Company Wet granulating method
EP1098636A1 (en) * 1998-07-23 2001-05-16 Novo Nordisk A/S A wet granulation method for preparing a stable pharmaceutical formulation
AU5750900A (en) * 1999-06-21 2001-01-09 Procter & Gamble Company, The Processes for making granular detergent in a fluidized bed granulator having recycling of improperly sized particles
CA2439468A1 (en) 2001-02-27 2002-09-06 Teva Pharmaceutical Industries Ltd. New crystal forms of lamotrigine and processes for their preparations
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
CA2483103A1 (en) * 2002-04-23 2003-11-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
EP1608342A2 (en) * 2003-03-21 2005-12-28 Ranbaxy Laboratories, Ltd. Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004103340A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Water dispersible tablets of lamotrigine
SI3395340T1 (sl) 2003-09-12 2019-08-30 Amgen, Inc. Hitrotopna formulacija, ki vsebuje cinakalcet HCL
WO2005115411A1 (ja) * 2004-05-31 2005-12-08 Senju Pharmaceutical Co, .Ltd. 透明組織可視化剤
US20100016322A1 (en) * 2007-02-28 2010-01-21 Nagesh Nagaraju Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
US20090022789A1 (en) * 2007-07-18 2009-01-22 Supernus Pharmaceuticals, Inc. Enhanced formulations of lamotrigine
BR112012022363A2 (pt) 2010-03-04 2016-07-05 Wockhardt Ltd forma de dosagem com liberação modificada
JP2019530727A (ja) * 2016-10-11 2019-10-24 オクタ ファーマシューティカルズ ラモトリギンを含む経口懸濁液用の粉末

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
EP0619283A3 (en) * 1989-06-30 1994-11-30 Sumitomo Electric Industries Substrate with a superconductive layer.
WO1992013527A1 (en) * 1991-01-30 1992-08-20 The Wellcome Foundation Limited Water-dispersible tablets
CA2277722C (en) * 1991-11-22 2001-03-27 The Wellcome Foundation Limited Water dispersible tablets
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700114A1 (fr) * 1993-01-07 1994-07-08 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
GB9305692D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
GB9305693D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
FR2702149B1 (fr) * 1993-06-03 1995-04-07 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement du neuro-sida.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets

Also Published As

Publication number Publication date
ATE213633T1 (de) 2002-03-15
DE69525649T2 (de) 2002-09-05
FI972434A0 (fi) 1997-06-06
DE69525649D1 (de) 2002-04-04
CN1174505A (zh) 1998-02-25
RU2160106C2 (ru) 2000-12-10
JP2977284B2 (ja) 1999-11-15
ES2172600T3 (es) 2002-10-01
GB9424766D0 (en) 1995-02-08
HUT77367A (hu) 1998-03-30
MX9704103A (es) 1997-09-30
PL320560A1 (en) 1997-10-13
NZ296573A (en) 1997-08-22
CA2207284A1 (en) 1996-06-13
AU696406B2 (en) 1998-09-10
EP0797441A1 (en) 1997-10-01
WO1996017611A1 (en) 1996-06-13
EP0797441B1 (en) 2002-02-27
CZ171797A3 (en) 1997-11-12
JPH10510255A (ja) 1998-10-06
BR9509975A (pt) 1998-06-09
US5861179A (en) 1999-01-19
NO972623L (no) 1997-08-06
FI972434A (fi) 1997-06-09
AU4121196A (en) 1996-06-26

Similar Documents

Publication Publication Date Title
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
AU2614995A (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
ATE212547T1 (de) Arzneizubereitungen enthaltend mikronisiertes nebivolol
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
SE9401596D0 (sv) New compounds
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application